Effectiveness and cost-effectiveness of Korean medicine and Western medicine collaborative treatment for MCI & Dementia- a prospective observational study

Wonkwang University Sanbon Hospital0 个研究点目标入组 180 人开始时间: 待定最近更新: 2019年3月11日

试验速览

暂无简介。

•1. adult-patients whose main diagnosis is MCI or dementia (ICD-10 F00, F01, F02, F03, F067, G30 or G31) equal to or below 85 years old among outpatients of participating institutions in the 'second stage pilot project of KM-WM collaborative treatment'.
•2. patiens whose global CDR score ranges 0.5 to 2.0 ( 0.5=CDR=2.0)
•3. patients who decide to participat in the study by their (or legal representative when the patient has limited ability to agree, but still can express willingness to participate) voluntary will and submit a written consent

•1. those who are currently participating other clinical trial
•2. thos who have difficulties in participating in the study as judged by researchers such as
•- those who are expected to have difficulty in complying the study schedule
•- those who are expected to have difficulty understanding and responding to study questionnaires such as illiteracy, mental and physical weakness

发起方

Wonkwang University Sanbon Hospital